Prodotti della ricerca
UNICA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Cagliari dal mese di luglio 2015.
Mostra risultati da 1 a 10 di 10
Esportazione
| Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore |
|---|---|---|---|---|
| Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy | 2017 | Cadeddu Dessalvi, Christian; Piras, Alessandra; Dessì, Mariele; Madeddu, Clelia; Mantovani, Giova...nni; Scartozzi, Mario; Hagendorff, Andreas; Colonna, Paolo; Mercuro, Giuseppe | THE INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING | |
| Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia | 2010 | Mantovani, G; Maccio, A; Madeddu, Clelia; Serpe, Roberto; Massa, Elena; Dessi', Mariele; Panzone,... F; Contu, Paolo | THE ONCOLOGIST | |
| Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia | 2010 | Madeddu, Clelia; Macciò, Antonio; Astara, G; Massa, Elena; Dessì, M; Antoni, Giorgia; Panzone, F;... Serpe, Roberto; Mantovani, Giovanni | MEDITERRANEAN JOURNAL OF NUTRITION AND METABOLISM | |
| Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia | 2010 | Mantovani, G; Maccio', A; Madeddu, Clelia; Serpe, Roberto; Antoni, G; Massa, Elena; Dessi', Marie...le; Panzone, F. | JOURNAL OF MOLECULAR MEDICINE | |
| Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment. Phase II study | 2009 | E MASSA; C. LOI; G. ASTARA; C. MADEDDU; DESSI' M; G. MANTOVANI | CRITICAL REVIEWS IN ONCOGENESIS | |
| Risultati preliminari di uno studio di fase II con Sorafenib in pazienti anziani affetti da epatocarcinoma | 2009 | Massa E; Chessa L; Madeddu C; Zolfino T; Liguori S; Marini S; Dessì M; Mantovani G | CANCER AND AGING | |
| Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers | 2008 | Mantovani, G; Madeddu, Clelia; CADEDDU DESSALVI, Christian; Dessi', Mariele; Piras, A; Massa, Ele...na; Serpe, Roberto; Antoni, G; Mercuro, Giuseppe | THE ONCOLOGIST | |
| Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results | 2008 | Mantovani G; Maccio A; Madeddu C; Gramignano G; Serpe R; Massa E; Dessi M; Tanca FM; Sanna E; Dei...ana L; Panzone F; Contu P; Floris C | NUTRITION | |
| Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers | 2007 | Mercuro, Giuseppe; CADEDDU DESSALVI, Christian; Piras, A; Dessi', Mariele; Madeddu, Clelia; Deidd...a, Martino; Serpe, Roberto; Massa, Elena; Mantovani, G. | THE ONCOLOGIST | |
| Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy | 2006 | Gramignano G; Lusso MR; Madeddu C; Massa E; Serpe R; Deiana L; Lamonica G; Dessì M; Spiga C; Asta...ra G; Macciò A; Mantovani G. | NUTRITION |
